摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

diaqua(iminodiacetato)copper(II) | 50697-21-7

中文名称
——
中文别名
——
英文名称
diaqua(iminodiacetato)copper(II)
英文别名
{copper(iminodiacetato)(H2O)2};[Cu(iminodiacetato)(H2O)2];[Cu(ida)(H2O)2];copper;2-(carboxylatomethylamino)acetate;dihydrate
diaqua(iminodiacetato)copper(II)化学式
CAS
50697-21-7;58188-20-8;836607-97-7
化学式
C4H9CuNO6
mdl
——
分子量
230.665
InChiKey
KVPZWIKAKLIOCD-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    咪唑diaqua(iminodiacetato)copper(II) 为溶剂, 以>90的产率得到
    参考文献:
    名称:
    Dung, Nguyen-Huy; Viossat, B.; Busnot, A., Inorganica Chimica Acta, 1990, vol. 174, p. 145 - 148
    摘要:
    DOI:
  • 作为产物:
    描述:
    、 copper dichloride 以 为溶剂, 生成 diaqua(iminodiacetato)copper(II)
    参考文献:
    名称:
    Poznyak, A. L.; Stopolyanskaya, L. V., Russian Journal of Inorganic Chemistry, 1995, vol. 40, p. 761 - 764
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Screening of metal complex–amino acid side chain interactions by potentiometric titration
    作者:Michael Kruppa、Daniel Frank、Helga Leffler-Schuster、Burkhard König
    DOI:10.1016/j.ica.2005.12.008
    日期:2006.3
    Reversible coordination of amino acid side chains to metal complexes is widely used in protein purification (IMAC technique), but available data on affinity and selectivity of such binding processes are limited. We use potentiometric titration of a series of metal complexes with vacant coordination sites in the presence of molecules resembling amino acid side chain functionalities to screen for new affinities. The investigation confirms documented affinities of imidazole to nickel(II) and copper(II) IDA and NTA complexes, and discovers a hitherto unknown binding of zinc(II)- and cadmium(II) cyclen complexes to imidazole. (c) 2005 Elsevier B.V. All rights reserved.
  • New mixed-ligand copper(II) complex with iminodiacetate and imidazole: Bis[bis(imidazole)(iminodiacetato)copper(II)] dihydrate
    作者:Nguyen-Huy Dung、B. Viossat、A. Busnot、A.G. Sicilia Zafra、J.M. Gonzalez Perez、J. Niclos Gutierrez
    DOI:10.1016/s0020-1693(00)82026-5
    日期:1990.3
  • Synthesis, XRD structures and properties of diaqua(iminodiacetato)copper(II), [Cu(IDA)(H2O)2], and aqua(benzimidazole)(iminodiacetato)copper(II), [Cu(IDA)(HBzIm)(H2O)]
    作者:M.J Román-Alpiste、J.D Martı́n-Ramos、A Castiñeiras-Campos、E Bugella-Altamirano、A.G Sicilia-Zafra、J.M González-Pérez、J Niclós-Gutiérrez
    DOI:10.1016/s0277-5387(99)00272-7
    日期:1999.11
    The stoichiometric reaction of copper(II) hydroxycarbonate with iminodiacetic acid (H(2)IDA) in water under reduced pressure yields good crystalline samples of [Cu(IDA)(H2O)(2)] (compound I). Using equimolar amounts of benzimidazole (HBzIm) the above reaction produces crystals of [Cu(IDA)(HBzIm)(H2O)] (compound II). Both compounds were characterised by TG analysis (with IR study of the evolved gasses in the pyrolysis), spectral and/or magnetic properties (IR, electronic, ESR spectrum, magnetic susceptibility in the 1.8-300 K range) and single crystal X-ray diffraction. The structure of I was re-determined (final R1 = 0.022) and it confirms the earlier reported distorted octahedral Cu(II) coordination (type 4 + 1 + 1), the fac-terdentate chelating and bridging roles for IDA ligand, as well as the 'polymeric' chain structure, but with a rather different hydrogen bonding network. In compound II (final R1 = 0.035) the Cu(II) exhibits a square base pyramidal coordination (type 4 + 1) and the IDA exhibits the mer-terdentate chelating configuration observed earlier for complexes having equimolar Cu(II)/IDA/HIm or Him-like ratio, but now with a large dihedral angle (31.3 degrees) between basal Cu(II) coordination and HBzIm mean planes. (C) 1999 Elsevier Science Ltd. All rights reserved.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸